SCHEMBL12376678

SCHEMBL12376678

CC(C)NC(=O)c1ccc(N2CCOCC2)nc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.61
HPGD P15428 2/20 0.61
KDM4E B2RXH2 1/20 0.61
POLB P06746 1/20 0.61
ALOX15 P16050 1/20 0.61
HSD17B10 Q99714 1/20 0.61
MAPT P10636 3/20 0.58
CYP1A2 P05177 2/20 0.58
CYP2C19 P33261 1/20 0.58
SMN1; SMN2 Q16637 3/20 0.55
LMNA P02545 1/20 0.55
HTT P42858 1/20 0.55
USP30 Q70CQ3 1/20 0.54
STAT3 P40763 1/20 0.53
HPGDS O60760 1/20 0.53
KCNQ3 O43525 1/20 0.52
KCNQ2 O43526 1/20 0.52
PRMT5 O14744 2/20 0.52
IKBKE Q14164 1/20 0.50
TBK1 Q9UHD2 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7679197 0.85 ALDH1A1 (0.66) ALDH1A1HPGDKDM4EPOLBALOX15
SCHEMBL25667152 0.82 ALDH1A1 (0.66) ALDH1A1HPGDKDM4EPOLBALOX15
SCHEMBL2570318 0.82 ALDH1A1 (0.66) ALDH1A1HPGDKDM4EPOLBALOX15
SCHEMBL13360509 0.82 ALDH1A1 (0.66) ALDH1A1HPGDKDM4EPOLBALOX15
SCHEMBL4930304 0.82 ALDH1A1 (0.66) ALDH1A1HPGDKDM4EPOLBALOX15
SCHEMBL64370 0.82 NPC1 (0.71) ALDH1A1HPGDKDM4EPOLBALOX15
SCHEMBL25725661 0.82 KDM4E (0.50) ALDH1A1HPGDKDM4EMAPTSMN1; SMN2
SCHEMBL13116111 0.82 ALDH1A1 (0.61) ALDH1A1HPGDKDM4EPOLBALOX15
SCHEMBL13101600 0.82 ALDH1A1 (0.61) ALDH1A1HPGDKDM4EPOLBALOX15
SCHEMBL3873495 0.82 ALDH1A1 (0.61) ALDH1A1HPGDKDM4EPOLBALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8003662-B2 Heterobicyclic thiophene compounds and methods of use ARRAY BIOPHARMA, INC. (US) 2011-08-23 US disclosed
US-7723330-B2 Heterobicyclic pyrazole compounds and methods of use ARRAY BIOPHARMA INC. (US) 2010-05-25 US disclosed
US-7723330-B2 Heterobicyclic pyrazole compounds and methods of use ARRAY BIOPHARMA INC. (US) 2010-05-25 US disclosed
WO-2008063202-A2 HETEROBICYCLIC THIOPHENE COMPOUNDS FOR THE TREATMENT OF CANCER ARRAY BIOPHARMA INC. (US) 2008-05-29 WO disclosed
US-20070238726-A1 Heterobicyclic pyrazole compounds and methods of use GENENTECH, INC. 2007-10-11 US disclosed
US-20070238726-A1 Heterobicyclic pyrazole compounds and methods of use GENENTECH, INC. 2007-10-11 US disclosed
US-20070197537-A1 Heterobicyclic thiophene compounds and methods of use ARRAY BIOPHARMA, INC. 2007-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197537-A1 Heterobicyclic thiophene compounds and methods of use ERBB2, LCK, SRC ALDH1A1 1635/4885HPGD 1640/4885KDM4E 3968/4885
US-20070238726-A1 Heterobicyclic pyrazole compounds and methods of use ROR1, CYP11B1, CYP11B2 ALDH1A1 1929/4885HPGD 842/4885KDM4E 4855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.